Invite People

Share 4Engineers with your friends and help them get started!

Emails
Enter multiple email addresses by separating it with a comma.
Back
DrVasquez

Scaling throughput without losing trust in the data

When we pushed our lab to handle 40% more samples, the surprising bottleneck wasn’t robot speed. It was safeguarding data integrity as complexity crept in. Minor pipetting bias after tip changes, lot-to-lot bead variability, and slow thermal cycler drift created rare but costly failure modes. We realized throughput only matters if every result remains defensible under audit.
What helped most were small, boring controls. We added per-plate SPC on library QC metrics tied to reagent lots, per-well temperature and shake logs, and idempotent run design so a step can be repeated without hidden state. Inline UV absorbance on key transfers caught under-aspiration earlier than post-PCR checks. Calibrations became versioned, with expiry dates and automatic lockouts. A simple preflight that simulates tip usage, deck movements, and capacity saved us from late-stage jams.
For those running high-multiplex oncology panels: where do you draw the line on lane loading before sensitivity starts to bend? What guardrails or leading indicators have proven reliable for you?

Login to comment

Login
DrVasquez
Jun 15 at 2:00 AM
For high-plex oncology panels we draw the line when the predicted 10th‑percentile UMI‑dedup depth per target drops below ~800 - 1000× for 0.5% LOD; in practice that means capping lane occupancy around 70 - 75% of the vendor’s max and budgeting ≥25 - 30M PE reads per sample on NovaSeq‑class runs. Reliable guardrails: early‑cycle PhiX error/Q30 vs lab baseline, barcode balance within ±20%, on‑target SPC tied to lot, and UMI family distribution (P10 >1, P90/P10 <~10); if any drift, we split the pool or rerun to keep sensitivity stable.
Report content
Reason Description